Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+
July 22, 2025 02:00 ET | Source: Scancell Holdings Plc SCOPE trial…
CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area
SHANGHAI, July 21, 2025 /PRNewswire/ -- CPHI & PMEC China 2025 concluded…
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias
AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac…
Darolutamide receives EU approval in third indication for patients with advanced prostate cancer
July 21, 2025 03:30 ET | Source: Orion Oyj ORION CORPORATION PRESS…
EssilorLuxottica to acquire PUcores division dedicated to the development, manufacturing and sale of ophthalmic lens materials
EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
July 18, 2025 16:05 ET | Source: HOOKIPA Pharma Inc. NEW YORK…
Huawei Launches Global Education and Healthcare Partner Alliance to Unleash Value in Industry Ecosystem
SHENZHEN, China, July 16, 2025 /PRNewswire/ -- Huawei held the 2025 Global…
New APOE4 App Uses AI Digital Twins to Help 25% of Population at High Alzheimer’s Risk
Phoenix platform matches users with genetically similar people to predict which interventions…
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 18, 2025 17:15 ET | Source: Iovance Biotherapeutics, Inc. SAN CARLOS,…